Literature DB >> 33495871

Controversies of colonic stenting in obstructive left colorectal cancer: a critical analysis with meta-analysis and meta-regression.

Vernicia Shu Qi Neo1, Sneha Rajiv Jain1, Jun Wei Yeo1, Cheng Han Ng1, Tiffany Rui Xuan Gan2, Emile Tan3, Choon Seng Chong4,5,6.   

Abstract

PURPOSE: After almost three decades since the first description of colonic stents, the controversies of its safe application continue to impede the readiness of adoption by clinicians for malignant left bowel obstruction. This review seeks to address some of the controversial aspects of stenting and its impact on surgical and oncological outcomes.
METHODS: Medline, Embase, and CNKI were searched for articles employing SEMS for left colonic obstruction. Outcomes analyzed include success rates, complications, and long-term survival. Pooled risk ratio (RR) and 95% confidence interval (CI) were estimated.
RESULTS: 36 studies were included with 2002 patients across seven randomized controlled trials and 29 observational studies. High technical (92%) and clinical (82%) success rates, and low rates of complications, including perforation (5%), were found. Those with > 8% perforation rates had poorer technical success rates than those with ≤ 8%, but there were no significant differences in 90-day in-hospital mortality and three and 5-year overall and disease-free survival. A significant increase was found in technical (RR = 1.094; CI, 1.041-1.149; p < 0.001) and clinical (RR = 1.158; CI, 1.064-1.259; p = 0.001) success rates when the duration between stenting and surgery was ≥ 2 weeks compared to < 2 weeks, but there were no significant differences in perforation rates, 90-day in-hospital mortality, and long-term survival.
CONCLUSIONS: Colonic stenting is safe and effective with high success rates and low complication rates. However, outcomes of higher perforation rates and optimal timing from stent till surgery remain unclear, with only a few studies reporting on these outcomes, leaving areas for future research.

Entities:  

Keywords:  Bridge to surgery; Colonic neoplasms; Meta-analysis; Palliative; Self-expanding metallic stent

Mesh:

Year:  2021        PMID: 33495871     DOI: 10.1007/s00384-021-03834-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  55 in total

1.  Imputing missing standard deviations in meta-analyses can provide accurate results.

Authors:  Toshi A Furukawa; Corrado Barbui; Andrea Cipriani; Paolo Brambilla; Norio Watanabe
Journal:  J Clin Epidemiol       Date:  2006-01       Impact factor: 6.437

2.  Colonic stenting for malignant large bowel obstruction is safe and effective: a single-surgeon experience.

Authors:  Man Hon Tang; Talisa Ross; Shen Ann Yeo; Chee Yung Ng
Journal:  Singapore Med J       Date:  2019-01-15       Impact factor: 1.858

3.  The separation of DPN-linked and TPN-linked isocitrate dehydrogenase activities of mammalian liver.

Authors:  G W Plaut; T Aogaichi
Journal:  Biochem Biophys Res Commun       Date:  1967-08-23       Impact factor: 3.575

4.  Bridge-to-surgery versus emergency surgery in the management of left-sided acute malignant colorectal obstruction - Efficacy, safety and long-term outcomes.

Authors:  Eduardo Rodrigues-Pinto; Rui Morais; Catarina Coelho; Pedro Pereira; Alessandro Repici; Guilherme Macedo
Journal:  Dig Liver Dis       Date:  2018-11-20       Impact factor: 4.088

5.  Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020.

Authors:  Jeanin E van Hooft; Joyce V Veld; Dirk Arnold; Regina G H Beets-Tan; Simon Everett; Martin Götz; Emo E van Halsema; James Hill; Gianpiero Manes; Soren Meisner; Eduardo Rodrigues-Pinto; Charles Sabbagh; Jo Vandervoort; Pieter J Tanis; Geoffroy Vanbiervliet; Alberto Arezzo
Journal:  Endoscopy       Date:  2020-04-07       Impact factor: 10.093

Review 6.  Expandable metal stents for malignant colorectal strictures.

Authors:  Alessandro Repici; Daniel de Paula Pessoa Ferreira
Journal:  Gastrointest Endosc Clin N Am       Date:  2011-05-14

Review 7.  Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis.

Authors:  Roberto Cirocchi; Eriberto Farinella; Stefano Trastulli; Jacopo Desiderio; Chiara Listorti; Carlo Boselli; Amilcare Parisi; Giuseppe Noya; Jayesh Sagar
Journal:  Surg Oncol       Date:  2012-11-24       Impact factor: 3.279

8.  Colorectal stenting in malignant large bowel obstruction: the learning curve.

Authors:  D Williams; R Law; A M Pullyblank
Journal:  Int J Surg Oncol       Date:  2010-10-11

9.  Estimating the mean and variance from the median, range, and the size of a sample.

Authors:  Stela Pudar Hozo; Benjamin Djulbegovic; Iztok Hozo
Journal:  BMC Med Res Methodol       Date:  2005-04-20       Impact factor: 4.615

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  2 in total

1.  Effect of self-expandable metal stent on morbidity and mortality and oncological prognosis in malignant colonic obstruction: retrospective analysis of its use as curative and palliative treatment.

Authors:  Carlos Bustamante Recuenco; Javier García Septiem; Javier Arias Díaz; Israel John Thuissard Vasallo; Alejandro Andonaegui de la Madriz; Virginia Jiménez Carneros; Jose Luis Ramos Rodríguez; José María Jover Navalón; Francisco Javier Jiménez Miramón
Journal:  Int J Colorectal Dis       Date:  2022-01-23       Impact factor: 2.571

2.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.